Nachrichten zur ChemoCentryx Aktie

ChemoCentryx downgraded to hold from buy at Stifel Nicolaus

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Shareholder Alert - The M&A Class Action Firm Announces the Investigation of ChemoCentryx, Inc. - CCXI

NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde &…

ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of…

Insiderhandel: President and CEO verkauft Aktien von ChemoCentryx im Wert von 6.531.733$

Schall, Thomas J. - Vorstand - Tag der Transaktion: 2022-08-04...…

Insiderhandel: EVP, CFO and Sec. verkauft Aktien von ChemoCentryx im Wert von 2.322.715$

Kanaya, Susan M. - Vorstand - Tag der Transaktion: 2022-08-04...…

Insiderhandel: Aufsichtsrat verkauft Aktien von ChemoCentryx im Wert von 502.200$

Tyree, James L. - Aufsichtsrat - Tag der Transaktion: 2022-08-04...…

Insiderhandel: Chief Bus. Officer & Treasurer verkauft Aktien von ChemoCentryx im Wert von 379.864$

Cappel, Markus J. - Vorstand - Tag der Transaktion: 2022-08-04...…

Biotech-Branche im Übernahmefieber: Amgen greift nach InflaRx-Konkurrenten

Das Übernahme-Karussell – wie vom AKTIONÄR erwartet – bleibt im Biotech-Sektor in Schwung. Vergangene Woche hat der Biotech-Gigant Amgen zugeschlagen…

Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx

Amgen (AMGN) beats Q2 estimates for earnings and sales. It offers to buy ChemoCentryx (CCXI) for $3.7 billion....…

ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last?

ChemoCentryx (CCXI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…

SHAREHOLDER ALERT: Weiss Law Investigates ChemoCentryx, Inc

NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of…

ChemoCentryx Shares up 110%, Amgen Agrees to Acquire Co.

ChemoCentryx Shares up 110%, Amgen Agrees to Acquire Co....…

Shareholder Alert: Ademi LLP investigates whether ChemoCentryx, Inc. has obtained a Fair Price in its transaction with Amgen

MILWAUKEE, Aug. 4, 2022 /PRNewswire/ -- Ademi LLP is investigating ChemoCentryx (NASDAQ: CCXI) for possible breaches of fiduciary duty and…

Why ChemoCentryx Stock Is On Fire Today

The rare-disease specialist is being bought out at a sizable premium....…

Amgen To Buy TAVNEOS Developer ChemoCentryx In $3.7 Bln Cash Deal

THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) Thursday said it has entered into a definitive agreement to acquire ChemoCentryx, Inc., (CCXI),…

Amgen Acquires Drugmaker ChemoCentryx for $3.7 Billion

With the acquisition, the biotech company adds a newly approved drug for an autoimmune disorder....…

ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal >CCXI

ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal >CCXI...…

ChemoCentryx soars 109% as Amgen agrees to buy for $3.7B in cash

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Amgen to gain rare-disease drug in $3.7 billion acquisition of ChemoCentryx

Amgen Inc. said Thursday it plans to buy ChemoCentryx Inc. for $3.7 billion in cash. The deal will…

UPDATE 1-Amgen to buy ChemoCentryx for $3.7 billion

...(Adds details on deal) Aug 4 (Reuters) - Amgen Inc said on Thursday......…

ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

-- Ms. Herron brings more than 25 years of therapeutics commercial experience and brand management to ChemoCentryx Board -- --…

Insiderhandel: Aufsichtsrat verkauft Aktien von ChemoCentryx im Wert von 99.129$

Tyree, James L. - Aufsichtsrat - Tag der Transaktion: 2022-06-09...…

Form 8-K ChemoCentryx, Inc. For: Jun 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ChemoCentryx, Inc. For: May 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences

SAN CARLOS, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming abstract presentations…

ChemoCentryx Announces Presentation at the Society for Investigative Dermatology Meeting Highlighting the Role of Tunnels in Driving Ongoing Disease in Hidradenitis Suppurativa

-- Supports plans to advance TAVNEOS®(avacopan) into Phase III development for the treatment of patients with most severe form of…

ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS® (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis

SAN CARLOS, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming presentations at…

ChemoCentryx (CCXI) Q1 Earnings and Sales Miss Estimates

ChemoCentryx (CCXI) posts a wider-than-anticipated Q1 loss and a revenue lag. However, product sales of CCXIs recently approved drug Tavneos…

ChemoCentryx surges 15% despite top and bottom lines quarterly misses

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why ChemoCentryx Shares Are Popping Off

ChemoCentryx Inc (NASDAQ: CCXI) shares are trading higher by 21.45% at $19.00 after the company reported first-quarter results. read more...…

Thinking about buying stock in Draftkings, ChemoCentryx, Opendoor Technologies, 1life Healthcare, or Enservco Corp?

NEW YORK, May 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DKNG, CCXI, OPEN, ONEM, and ENSV. To…

ChemoCentryx Jumps on 1Q Results

ChemoCentryx Jumps on 1Q Results...…

ChemoCentryx: Q1 Earnings Insights

ChemoCentryx (NASDAQ:CCXI) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:05 PM. Heres what investors need to know…

Form 8-K ChemoCentryx, Inc. For: May 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ChemoCentryx, Inc. For: May 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ChemoCentryx Posts Favorable PK, PD Results Of Oral PD-L1 Inhibitor In Cancer

ChemoCentryx solid tumors candidate shows immune stimulation properties in phase 1 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Is ChemoCentryx (CCXI) Up 1.8% Since Last Earnings Report?

ChemoCentryx (CCXI) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

ChemoCentryx, Inc. 2021 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ChemoCentryx: Good Post-Approval Performance, But Needs More Time

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ChemoCentryx (CCXI) Q4 Earnings and Sales Miss Estimates

ChemoCentryx (CCXI) posts a wider year-over-year loss in the fourth quarter and sales miss estimates. Lead drug Tavneos has…

ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K ChemoCentryx, Inc. For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Recap: ChemoCentryx Q4 Earnings

ChemoCentryx (NASDAQ:CCXI) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Heres what investors need to know…

Form 8-K ChemoCentryx, Inc. For: Feb 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Now The Time To Buy Stock In ChemoCentryx, Ideanomics Or Snowflake?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by…

CHEMOCENTRYX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI

NEW ORLEANS, Feb. 18, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…